Impact of discrepancies between the Abbott RealTime and Cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes

M. Wirden*, R. Tubiana, F. Marguet, I. Leroy, A. Simon, M. Bonmarchand, Z. Ait-Arkoub, R. Murphy, A. G. Marcelin, C. Katlama, V. Calvez

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

Viral loads in 249 clinical samples from individual patients infected with human immunodeficiency virus type 1 non-B subtypes were determined with both the Abbott RealTime and Cobas TaqMan assays. The differences exceeded 0.5 log for about 20% of samples and 1 log for 3%, with higher values always from the Abbott assay in the latter cases.

Original languageEnglish (US)
Pages (from-to)1543-1545
Number of pages3
JournalJournal of clinical microbiology
Volume47
Issue number5
DOIs
StatePublished - May 2009

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Impact of discrepancies between the Abbott RealTime and Cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes'. Together they form a unique fingerprint.

Cite this